Skip to main content
Equibles

Marvin Slosman

CEO

InspireMD, Inc. (NSPR)

Board Member

InspireMD, Inc. (NSPR)

Equibles does not estimate personal net worth.

Get an email with a short summary when InspireMD, Inc. publishes a filing, an earnings call transcript or a press release.

Get NSPR alerts

About Marvin Slosman

Marvin Slosman is recorded as CEO and Board Member at InspireMD, Inc. (NSPR). The newest filing on record that lists Marvin Slosman as CEO and Board Member at InspireMD, Inc. (NSPR) is dated April 20, 2026. The proxy statement of InspireMD, Inc. reports total compensation of $3,095,187 for Marvin Slosman in fiscal 2025, including a base salary of $588,500. Disclosed compensation is on record for 6 fiscal years. Marvin Slosman has spoken on 25 earnings calls across 1 company, most recently for InspireMD, Inc. on August 17, 2026. InspireMD, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at InspireMD, Inc. includes Paul Stuka (Chairman), Amir Kohen (CFO), Michael Lawless (CFO) and 7 others.

Marvin Slosman on recent calls

“I think the wiggle, as you mentioned it, is we're just trying to be realistic about the regulatory timeframes as always, requests from FDA and just general timeframes.”
CEO, InspireMD, Inc. Q2 FY2026 Earnings Call ·
“Starting with our Q1 results, our first quarter revenue of 3.4 million dollars was a strong start to 2026, representing growth of over 120 percent.”
CEO, InspireMD, Inc. Q4 FY2025 Earnings Call ·
“I'm pleased to welcome you to today's call. Joining me on the line is Mike Lawless, our Chief Financial Officer; and Shane Gleason, our Chief Commercial Officer.”
CEO, InspireMD, Inc. Q3 FY2025 Earnings Call ·
“We're happy to welcome you to today's call at this exciting and transformative moment for our company. Before we review our recent progress and second quarter results, I'd like to take a moment to formally welcome Mike Lawless, our new Chief Financial Officer.”
CEO, InspireMD, Inc. Q2 FY2025 Earnings Call ·
“We're pleased to welcome everyone to the call today. I'd like to start by highlighting our first quarter performance. CGuard revenue reached $1.53 million, reflecting a 1.2% growth year-over-year.”
CEO, InspireMD, Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at InspireMD, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 InspireMD, Inc. (NSPR) $588,500 $3,095,187
2024 InspireMD, Inc. (NSPR) $550,000 $3,300,762
2023 InspireMD, Inc. (NSPR) $470,000 $3,219,321
2022 InspireMD, Inc. (NSPR) $432,500 $696,809
2021 InspireMD, Inc. (NSPR) $410,000 $1,636,144
2020 InspireMD, Inc. (NSPR) $366,666 $1,382,118

Recent activity

Show 13 earlier activities